Pharma Mar, S.A. (BME:PHM)

Pharma Mar Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,554	1,389	738	1,158	1,033	1,313
Market Cap Growth	148.92%	88.09%	-36.23%	12.13%	-21.36%	66.27%
Enterprise Value	1,477	1,298	608	1,014	866	1,176
Last Close Price	88.40	79.02	39.98	61.69	54.28	67.24
PE Ratio	36.98	53.17	649.51	23.46	11.12	9.57
Forward PE	23.13	36.29	67.76	16.74	12.76	10.53
PS Ratio	8.21	7.94	4.67	5.90	4.49	4.87
PB Ratio	7.71	6.67	3.82	5.19	5.81	12.78
P/TBV Ratio	7.75	6.70	3.84	5.22	5.84	12.91
P/FCF Ratio	874.79	-	-	39.30	57.78	4.76
P/OCF Ratio	176.55	230.47	-	30.22	40.22	4.71
EV/Sales Ratio	7.80	7.42	3.84	5.17	3.77	4.36
EV/EBITDA Ratio	38.82	128.91	-	22.60	9.12	7.39
EV/EBIT Ratio	46.98	200.70	-	24.11	9.37	7.51
EV/FCF Ratio	831.61	-	-	34.42	48.46	4.26
Debt / Equity Ratio	0.26	0.25	0.23	0.19	0.28	0.55
Debt / EBITDA Ratio	1.35	4.19	48.68	0.91	0.51	0.35
Debt / FCF Ratio	28.94	-	-	1.45	2.76	0.21
Asset Turnover	0.57	0.51	0.43	0.52	0.66	1.19
Inventory Turnover	0.19	0.18	0.29	0.71	1.46	1.32
Quick Ratio	2.14	2.29	1.98	2.18	2.93	2.31
Current Ratio	2.84	3.03	2.63	2.83	3.42	2.59
Return on Equity (ROE)	21.94%	13.00%	0.55%	24.62%	66.18%	249.16%
Return on Assets (ROA)	5.91%	1.17%	-0.65%	6.91%	16.54%	43.04%
Return on Capital (ROIC)	8.30%	1.63%	-0.95%	10.67%	29.89%	77.41%
Return on Capital Employed (ROCE)	12.10%	2.40%	-	14.20%	32.80%	66.60%
Earnings Yield	2.70%	1.88%	0.15%	4.26%	8.99%	10.45%
FCF Yield	0.11%	-0.65%	-3.83%	2.54%	1.73%	21.01%
Dividend Yield	0.90%	1.01%	1.63%	1.05%	1.20%	0.89%
Payout Ratio	33.20%	43.71%	1028.06%	23.83%	11.71%	6.42%
Buyback Yield / Dilution	-	1.98%	0.81%	0.12%	1.31%	0.77%
Total Shareholder Return	0.90%	2.99%	2.44%	1.18%	2.51%	1.66%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.